Hematopoietic stem cell transplantation between red cell incompatible donor–recipient pairs

被引:0
作者
SD Rowley
机构
[1] Adult Allogeneic Stem Cell Transplant Program,
[2] Hackensack University Medical Center,undefined
来源
Bone Marrow Transplantation | 2001年 / 28卷
关键词
bone marrow transplantation; HSC transplantation; isoagglutinin; ABO compatibility; hemolytic reactions;
D O I
暂无
中图分类号
学科分类号
摘要
Transplantation between red cell-disparate donor and recipient is feasible with minimal increase in the risk of transplantation if consideration is given to the immunohematological consequences of the transplant. The risks of immediate and delayed hemolysis must be managed. Some recipients will experience a delay in the recovery of red blood cells. Bone Marrow Transplantation (2001) 28, 315–321.
引用
收藏
页码:315 / 321
页数:6
相关论文
共 124 条
[31]  
McGurk S(1981)Severe delayed hemolytic transfusion reaction complicating an ABO-incompatible bone marrow transplantation Blood 57 147-151
[32]  
Bar BMAM(1998)Expression of blood group A antigens in human bone marrow cells Transfusion 38 247-251
[33]  
Van Dijk BA(1988)Severe hemolytic anemia due to multiple red cell alloantibodies after an ABO-incompatible allogeneic bone marrow transplant Transplantation 45 530-534
[34]  
Schattenberg A(2000)Immunohematologic consequences of major ABO-mismatched bone marrow transplantation Blood 96 1150-1156
[35]  
Hows J(1997)Graft-versus-host disease and donor-directed hemagglutinin titers after ABO-mismatched related and unrelated marrow allografts: evidence for a graft-versus-plasma cell effect Bone Marrow Transplant 20 1105-1107
[36]  
Beddow K(1994)successful treatment of pure red cell aplasia after major ABO-incompatible T cell-depleted bone marrow transplantation with erythropoietin Bone Marrow Transplant 13 335-336
[37]  
Gordon-Smith E(1992)Treatment of pure red cell aplasia after major ABO-incompatible bone marrow transplantation resistant to erythropoietin Bone Marrow Transplant 10 471-472
[38]  
Gajewski JL(1998)Antilymphocyte globulin for treatment of pure red cell aplasia after major ABO incompatible marrow transplant Bone Marrow Transplant 22 605-607
[39]  
Petz LD(1986)CD34 Scand J Haematol 37 1-3
[40]  
Calhoun L(1988)-enriched donor lymphocyte infusions in a case of pure red cell aplasia and late graft failure after major ABO-incompatible bone marrow transplantation J Immunol 141 410-416